[1]
“Oral bioavailability enhancement of doxazosin mesylate: Nanosuspension versus self-nanoemulsifying drug delivery systems”, ADMET DMPK, vol. 12, no. 1, pp. 167–176, Nov. 2023, doi: 10.5599/admet.2022.